← Moderna, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $658.4m | $235.9m | $2.6b | $6.8b | $3.2b | $2.9b | $1.9b | $2.6b | |
| Accounts receivable, net | $11.7m | $5.0m | $1.4b | $3.2b | $1.4b | $892.0m | $358.0m | $184.0m | |
| Inventory | — | $0 | $46.5m | $1.4b | $949.0m | $202.0m | $117.0m | $153.0m | |
| Prepaid expenses and other current assets | $28.4m | $19.4m | $252.2m | $728.0m | $1.2b | $627.0m | $599.0m | $408.0m | |
| Total current assets | $1.6b | $1.1b | $6.3b | $16.1b | $13.4b | $10.3b | $8.1b | $6.5b | |
| Property, plant and equipment, net | $212.0m | $201.5m | $296.9m | $1.2b | $2.0b | $1.9b | $2.2b | $2.1b | |
| Right-of-use assets, operating leases | — | $86.4m | $90.2m | $142.0m | $121.0m | $713.0m | $759.0m | $719.0m | |
| Investments | $863.1m | $867.1m | $2.0b | $3.9b | $6.7b | $5.7b | $5.1b | $3.2b | |
| Investments, non-current | $173.0m | $160.0m | $638.8m | $6.8b | $8.3b | $4.7b | $2.5b | $2.3b | |
| Other non-current assets | $2.6m | $1.9m | $1.9m | $34.0m | $988.0m | $685.0m | $594.0m | $605.0m | |
| Deferred revenue | $109.1m | $63.3m | $3.9b | $6.3b | $2.0b | $568.0m | $153.0m | $99.0m | |
| Other current liabilities | $3.5m | $5.1m | $33.7m | $225.0m | $249.0m | $66.0m | $221.0m | $185.0m | |
| Operating lease liabilities, non-current | — | $93.7m | $97.4m | $106.0m | $92.0m | $643.0m | $671.0m | $653.0m | |
| Financing lease liabilities, non-current | — | $38.7m | $109.9m | $599.0m | $912.0m | $575.0m | $39.0m | $20.0m | |
| Other non-current liabilities | $258k | $138k | $1.9m | $76.0m | $135.0m | $256.0m | $267.0m | $285.0m | |
| Total stockholders’ equity | $1.5b | $1.2b | $2.6b | $14.1b | $19.1b | $13.9b | $10.9b | $8.7b | |
| Total assets | $2.0b | $1.6b | $7.3b | $24.7b | $25.9b | $18.4b | $14.1b | $12.3b | |
| Total liabilities and stockholders’ equity | $2.0b | $1.6b | $7.3b | $24.7b | $25.9b | $18.4b | $14.1b | $12.3b | |
| Accounts payable | $31.2m | $7.1m | $18.4m | $302.0m | $487.0m | $520.0m | $405.0m | $317.0m | |
| Accrued liabilities | $79.1m | $67.7m | $469.6m | $1.5b | $2.1b | $1.8b | $1.4b | $1.4b | |
| Deferred revenue, non-current | $165.4m | $139.0m | $177.4m | $615.0m | $673.0m | $83.0m | $58.0m | $153.0m | |
| Total current liabilities | $222.8m | $143.1m | $4.4b | $9.1b | $4.9b | $3.0b | $2.2b | $2.0b | |
| Long-term debt | — | — | — | — | — | — | $0 | $590.0m | |
| Total liabilities | $431.9m | $414.6m | $4.8b | $10.5b | $6.7b | $4.6b | $3.2b | $3.7b | |
| Preferred stock, $0.0001; 162 shares authorized as of December 31, 2025 and 2024; no shares issued or outstanding at December 31, 2025 and 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, par value $0.0001; 1,600 shares authorized as of December 31, 2025 and 2024; 394 and 386 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 33k | 34k | 40k | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | $2.5b | $2.7b | $4.8b | $4.2b | $1.2b | $371.0m | $866.0m | $1.4b | |
| Accumulated other comprehensive income (loss) | ($1.3m) | $1.8m | $3.0m | ($24.0m) | ($370.0m) | ($123.0m) | ($10.0m) | $45.0m | |
| Retained earnings | ($1.0b) | ($1.5b) | ($2.2b) | $10.0b | $18.3b | $13.6b | $10.0b | $7.2b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.